Innovations in Breaking Barriers: Liposomes as Near-Perfect Drug Carriers in Ischemic Stroke Therapy

References

• Nayab DE, Din FU, Ali H, et al. Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective. J Nanobiotechnology. 2023;21(1):477. doi:10.1186/s12951-023-02250-1
   PubMed Web of Science ®Google Scholar
• Zhu ZH, Jia F, Ahmed W, et al. Neural stem cell-derived exosome as a nano-sized carrier for BDNF delivery to a rat model of ischemic stroke. Neural Regen Res. 2023;18(2):404–409. doi:10.4103/1673-5374.346466
   PubMed Web of Science ®Google Scholar
• Sisubalan N, Shalini R, Ramya S, Sivamaruthi BS, Chaiyasut C. Recent advances in nanomaterials for neural applications: opportunities and challenges. Nanomedicine. 2023;18(26):1979–1994. doi:10.2217/nnm-2023-0261
   PubMed Web of Science ®Google Scholar
• Xing J, Liu D, Zhou G, et al. Liposomally formulated phospholipid-conjugated novel near-infrared fluorescence probe for particle size effect on cellular uptake and biodistribution in vivo. Colloids Surf B Biointerfaces. 2018;161:588–596. doi:10.1016/j.colsurfb.2017.11.033
   PubMed Web of Science ®Google Scholar
• Polak R, Lim RM, Beppu MM, Pitombo RN, Cohen RE, Rubner MF. Liposome-loaded cell backpacks. Adv Healthc Mater. 2015;4(18):2832–2841. doi:10.1002/adhm.201500604
   PubMed Web of Science ®Google Scholar
• Filipczak N, Pan J, Yalamarty S, Torchilin VP. Recent advancements in liposome technology. Adv Drug Deliv Rev. 2020;156:4–22. doi:10.1016/j.addr.2020.06.022
   PubMed Web of Science ®Google Scholar
• Ding Q, Liu S, Yao Y, Liu H, Cai T, Han L. Global, regional, and national burden of ischemic stroke, 1990–2019. Neurology. 2022;98(3):e279–e290. doi:10.1212/WNL.0000000000013115
   PubMed Web of Science ®Google Scholar
• Ahmed W, Kuniyan MS, Jawed AM, Chen L. Engineered extracellular vesicles for drug delivery in therapy of stroke. Pharmaceutics. 2023;15(9):2173. doi:10.3390/pharmaceutics15092173
   PubMed Web of Science ®Google Scholar
• Georgakis MK, Gill D, Rannikmäe K, et al. Genetically determined levels of circulating cytokines and risk of stroke. Circulation. 2019;139(2):256–268. doi:10.1161/CIRCULATIONAHA.118.035905
   PubMed Web of Science ®Google Scholar
• Chen C-Y, Lin P-T, Wang Y-H, et al. Etiology and risk factors of intracranial hemorrhage and ischemic stroke in young adults. J Chin Med Assoc. 2021;84(10):930–936. doi:10.1097/JCMA.0000000000000598
   PubMed Web of Science ®Google Scholar
• Tian D-Y, Fan D-S. Risk factors, regional disparity and trends of ischemic stroke etiologic subtypes. Chin Med J. 2018;131(2):127–129. doi:10.4103/0366-6999.222332
   PubMed Web of Science ®Google Scholar
• Ogata J, Masuda J, Yutani C, Yamaguchi T. Mechanisms of cerebral artery thrombosis: a histopathological analysis on eight necropsy cases. J Neurol Neurosurg Psychiatry. 1994;57(1):17–21. doi:10.1136/jnnp.57.1.17
   PubMed Web of Science ®Google Scholar
• Stoll G, Kleinschnitz C, Nieswandt B. Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood. 2008;112(9):3555–3562. doi:10.1182/blood-2008-04-144758
   PubMed Web of Science ®Google Scholar
• Zöller B, Sundquist J, Sundquist K, Ohlsson H. The risk for venous thromboembolism and cardiometabolic disorders in offspring from thrombosis-prone pedigrees. J Thromb Haemost. 2024;22(3):775–784. doi:10.1016/j.jtha.2023.11.024
   PubMed Web of Science ®Google Scholar
• Feske SK. Ischemic Stroke. Am J Med. 2021;134(12):1457–1464. doi:10.1016/j.amjmed.2021.07.027
   PubMedGoogle Scholar
• Liu J, Wang Y, Akamatsu Y, et al. Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials. Prog Neurobiol. 2014;115:138–156. doi:10.1016/j.pneurobio.2013.11.004
   PubMed Web of Science ®Google Scholar
• Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD. Global brain inflammation in stroke. Lancet Neurol. 2019;18(11):1058–1066. doi:10.1016/S1474-4422(19)30078-X
   PubMed Web of Science ®Google Scholar
• Jokivarsi KT, Gröhn HI, Gröhn OH, Kauppinen RA. Proton transfer ratio, lactate, and intracellular pH in acute cerebral ischemia. Magn Reson Med. 2007;57(4):647–653. doi:10.1002/mrm.21181
   PubMed Web of Science ®Google Scholar
• Larkin JR, Foo LS, Sutherland BA, Khrapitchev A, Tee YK. Magnetic Resonance pH imaging in stroke - combining the old with the new. Front Physiol. 2021;12:793741. doi:10.3389/fphys.2021.793741
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Sikdar SK. Intracellular activation of full-length human TREK-1 channel by hypoxia, high lactate, and low pH denotes polymodal integration by ischemic factors. Pflugers Arch. 2021;473(2):167–183. doi:10.1007/s00424-020-02471-5
   PubMed Web of Science ®Google Scholar
• Dénes A, Ferenczi S, Kovács KJ. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size. J Neuroinflammation. 2011;8:164. doi:10.1186/1742-2094-8-164
   PubMed Web of Science ®Google Scholar
• Bui TA, Jickling GC, Winship IR. Neutrophil dynamics and inflammaging in acute ischemic stroke: a transcriptomic review. Front Aging Neurosci. 2022;14:1041333. doi:10.3389/fnagi.2022.1041333
   PubMed Web of Science ®Google Scholar
• Ceulemans AG, Zgavc T, Kooijman R, Hachimi-Idrissi S, Sarre S, Michotte Y. The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation. 2010;7:74. doi:10.1186/1742-2094-7-74
   PubMed Web of Science ®Google Scholar
• Larsson SC, Virtamo J, Wolk A. Potassium, calcium, and magnesium intakes and risk of stroke in women. Am J Epidemiol. 2011;174(1):35–43. doi:10.1093/aje/kwr051
   PubMed Web of Science ®Google Scholar
• Johnson LS, Mattsson N, Sajadieh A, Wollmer P, Söderholm M. Serum potassium is positively associated with stroke and mortality in the large, population-based malmö preventive project cohort. Stroke. 2017;48(11):2973–2978. doi:10.1161/STROKEAHA.117.018148
   PubMed Web of Science ®Google Scholar
• András IE, Deli MA, Veszelka S, Hayashi K, Hennig B, Toborek M. The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J Cereb Blood Flow Metab. 2007;27(8):1431–1443. doi:10.1038/sj.jcbfm.9600445
   PubMed Web of Science ®Google Scholar
• Song M, Yu SP. Ionic regulation of cell volume changes and cell death after ischemic stroke. Transl Stroke Res. 2014;5(1):17–27. doi:10.1007/s12975-013-0314-x
   PubMed Web of Science ®Google Scholar
• Ren C, Guingab-Cagmat J, Kobeissy F, et al. A neuroproteomic and systems biology analysis of rat brain post intracerebral hemorrhagic stroke. Brain Res Bull. 2014;102:46–56. doi:10.1016/j.brainresbull.2014.02.005
   PubMed Web of Science ®Google Scholar
• Zheng Z, Yenari MA. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol Res. 2004;26(8):884–892. doi:10.1179/016164104X2357
   PubMed Web of Science ®Google Scholar
• Jolugbo P, Ariëns R. Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke. Stroke. 2021;52(3):1131–1142. doi:10.1161/STROKEAHA.120.032810
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Katsanos AH, Sandset EC, et al. Thrombolysis for acute ischaemic stroke: current status and future perspectives. Lancet Neurol. 2023;22(5):418–429. doi:10.1016/S1474-4422(22)00519-1
   PubMed Web of Science ®Google Scholar
• Diener HC, Hankey GJ. Primary and secondary prevention of ischemic stroke and cerebral hemorrhage: JACC focus seminar. J Am Coll Cardiol. 2020;75(15):1804–1818. doi:10.1016/j.jacc.2019.12.072
   PubMed Web of Science ®Google Scholar
• Li S, Pan Y, Wang Z, et al. Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled Phase II study. Stroke Vasc Neurol. 2022;7(1):47–53. doi:10.1136/svn-2021-000978
   PubMedGoogle Scholar
• Atchaneeyasakul K, Desai S, Malhotra K, et al. Intravenous tPA delays door-to-puncture time in acute ischemic stroke with large vessel occlusion. J Stroke Cerebrovasc Dis. 2021;30(6):105732. doi:10.1016/j.jstrokecerebrovasdis.2021.105732
   PubMed Web of Science ®Google Scholar
• Shah S, Liang L, Kosinski A, et al. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: findings From Get With The Guidelines-Stroke. Circ Cardiovasc Qual Outcomes. 2020;13(1):e006031. doi:10.1161/CIRCOUTCOMES.119.006031
   PubMed Web of Science ®Google Scholar
• Wang R, Zhu Y, Liu Z, et al. Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke. Blood. 2021;138(1):91–103. doi:10.1182/blood.2020008913
   PubMed Web of Science ®Google Scholar
• Charidimou A, Pasi M. Microbleeds evolution and remote hemorrhage post-tPA: ”Red meets white” revisited. Neurology. 2019;92(7):307–308. doi:10.1212/WNL.0000000000006933
   PubMed Web of Science ®Google Scholar
• Shi K, Zou M, Jia DM, et al. tPA mobilizes immune cells that exacerbate hemorrhagic transformation in stroke. Circ Res. 2021;128(1):62–75. doi:10.1161/CIRCRESAHA.120.317596
   PubMed Web of Science ®Google Scholar
• Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM. The neurotoxicity of tissue plasminogen activator. J Cereb Blood Flow Metab. 2004;24(9):945–963. doi:10.1097/01.WCB.0000137868.50767.E8
   PubMed Web of Science ®Google Scholar
• Wang W, Li M, Chen Q, Wang J. Hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke: mechanisms, models, and biomarkers. Mol Neurobiol. 2015;52(3):1572–1579. doi:10.1007/s12035-014-8952-x
   PubMed Web of Science ®Google Scholar
• Tsuji K, Aoki T, Tejima E, et al. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke. 2005;36(9):1954–1959. doi:10.1161/01.STR.0000177517.01203.eb
   PubMed Web of Science ®Google Scholar
• Montaner J, Molina CA, Monasterio J, et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation. 2003;107(4):598–603. doi:10.1161/01.cir.0000046451.38849.90
   PubMed Web of Science ®Google Scholar
• Wang Z, Shan W, Cao J, Wintermark M, Huang W, Zuo Z. Early administration of pyrrolidine dithiocarbamate extends the therapeutic time window of tissue plasminogen activator in a male rat model of embolic stroke. J Neurosci Res. 2018;96(3):449–458. doi:10.1002/jnr.24186
   PubMed Web of Science ®Google Scholar
• Tan Z, Lucke-Wold BP, Logsdon AF, et al. Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats. Eur J Pharmacol. 2015;764:404–412. doi:10.1016/j.ejphar.2015.07.035
   PubMed Web of Science ®Google Scholar
• Li Q, Han X, Lan X, et al. Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia. Neurobiol Dis. 2017;108:173–182. doi:10.1016/j.nbd.2017.08.011
   PubMed Web of Science ®Google Scholar
• Wisløff T, Hamidi V, Ringerike T, Harboe I, Klemp M. Intravenous Thrombolytic Treatment After Acute Stroke and Secondary Antithrombotic Prevention Treatment (Antiplatelet and Anticoagulant Treatment) After Stroke. Oslo, Norway; 2010.
   Google Scholar
• Bala MM, Celinska-Lowenhoff M, Szot W, et al. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Cochrane Database Syst Rev. 2020;10(10):CD012169. doi:10.1002/14651858.CD012169.pub3
   PubMedGoogle Scholar
• Jia YM, Ge PX, Zhou H, et al. Vicagrel enhances aspirin-induced inhibition of both platelet aggregation and thrombus formation in rodents due to its decreased metabolic inactivation. Biomed Pharmacother. 2019;115:108906. doi:10.1016/j.biopha.2019.108906
   PubMed Web of Science ®Google Scholar
• Kamel H, Healey JS. Cardioembolic Stroke. Circ Res. 2017;120(3):514–526. doi:10.1161/CIRCRESAHA.116.308407
   PubMed Web of Science ®Google Scholar
• Adams PC, Cohen M, Chesebro JH, Fuster V. Thrombosis and embolism from cardiac chambers and infected valves. J Am Coll Cardiol. 1986;8(6 Suppl B):76B–87B. doi:10.1016/s0735-1097(86)80009-2
   PubMed Web of Science ®Google Scholar
• Kamarova M, Baig S, Patel H, et al. Antiplatelet use in ischemic stroke. Ann Pharmacother. 2022;56(10):1159–1173. doi:10.1177/10600280211073009
   PubMed Web of Science ®Google Scholar
• Ovbiagele B, Kidwell CS, Starkman S, Saver JL. Neuroprotective agents for the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep. 2003;3(1):9–20. doi:10.1007/s11910-003-0031-z
   PubMedGoogle Scholar
• Lee JM, Zipfel GJ, Choi DW. The changing landscape of ischaemic brain injury mechanisms. Nature. 1999;399(6738 Suppl):A7–14. doi:10.1038/399a007
   PubMed Web of Science ®Google Scholar
• Yang JL, Mukda S, Chen SD. Diverse roles of mitochondria in ischemic stroke. Redox Biol. 2018;16:263–275. doi:10.1016/j.redox.2018.03.002
   PubMed Web of Science ®Google Scholar
• Lazarewicz JW, Pluta R, Puka M, Salinska E. Diverse mechanisms of neuronal protection by nimodipine in experimental rabbit brain ischemia. Stroke. 1990;21(12 Suppl):1.
   PubMed Web of Science ®Google Scholar
• Wu QJ, Tymianski M. Targeting NMDA receptors in stroke: new hope in neuroprotection. Mol Brain. 2018;11(1):15. doi:10.1186/s13041-018-0357-8
   PubMedGoogle Scholar
• Wang Z, Zhou Z, Wei X, et al. Therapeutic potential of novel twin compounds containing tetramethylpyrazine and carnitine substructures in experimental ischemic stroke. Oxid Med Cell Longev. 2017;2017:7191856. doi:10.1155/2017/7191856
   PubMed Web of Science ®Google Scholar
• Luo Y, Tang H, Li H, Zhao R, Huang Q, Liu J. Recent advances in the development of neuroprotective agents and therapeutic targets in the treatment of cerebral ischemia. Eur J Med Chem. 2019;162:132–146. doi:10.1016/j.ejmech.2018.11.014
   PubMed Web of Science ®Google Scholar
• Karunakaran B, Gupta R, Patel P, et al. Emerging trends in lipid-based vaccine delivery: a special focus on developmental strategies, fabrication methods, and applications. Vaccines (Basel). 2023;11(3):661. doi:10.3390/vaccines11030661
   PubMed Web of Science ®Google Scholar
• Has C, Sunthar P. A comprehensive review on recent preparation techniques of liposomes. J Liposome Res. 2020;30(4):336–365. doi:10.1080/08982104.2019.1668010
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36–48. doi:10.1016/j.addr.2012.09.037
   PubMed Web of Science ®Google Scholar
• Bulbake U, Doppalapudi S, Kommineni N, Khan W. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 2017;9(2):12. doi:10.3390/pharmaceutics9020012
   PubMed Web of Science ®Google Scholar
• Bondì ML, Di Gesù R, Craparo EF. Lipid nanoparticles for drug targeting to the brain. Methods Enzymol. 2012;508:229–251. doi:10.1016/B978-0-12-391860-4.00012-4
   PubMed Web of Science ®Google Scholar
• Joshi S, Singh-Moon R, Wang M, et al. Cationic surface charge enhances early regional deposition of liposomes after intracarotid injection. J Neurooncol. 2014;120(3):489–497. doi:10.1007/s11060-014-1584-1
   PubMed Web of Science ®Google Scholar
• Zhou Y, Peng Z, Seven ES, Leblanc RM. Crossing the blood-brain barrier with nanoparticles. J Control Release. 2018;270:290–303. doi:10.1016/j.jconrel.2017.12.015
   PubMed Web of Science ®Google Scholar
• de Lange E, Hammarlund Udenaes M. Understanding the blood-brain barrier and beyond: challenges and opportunities for novel CNS therapeutics. Clin Pharmacol Ther. 2022;111(4):758–773. doi:10.1002/cpt.2545
   PubMed Web of Science ®Google Scholar
• Kashyap K, Shukla R. Drug delivery and targeting to the brain through nasal route: mechanisms, applications and challenges. Curr Drug Deliv. 2019;16(10):887–901. doi:10.2174/1567201816666191029122740
   PubMed Web of Science ®Google Scholar
• Agrawal M, Saraf S, Saraf S, et al. Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release. 2018;281:139–177. doi:10.1016/j.jconrel.2018.05.011
   PubMed Web of Science ®Google Scholar
• Crowe TP, Greenlee M, Kanthasamy AG, Hsu WH. Mechanism of intranasal drug delivery directly to the brain. Life Sci. 2018;195:44–52. doi:10.1016/j.lfs.2017.12.025
   PubMed Web of Science ®Google Scholar
• Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A. 1988;85(18):6949–6953. doi:10.1073/pnas.85.18.6949
   PubMed Web of Science ®Google Scholar
• Price CD, Yang Z, Karlnoski R, Kumar D, Chaparro R, Camporesi EM. Effect of continuous infusion of asialoerythropoietin on short-term changes in infarct volume, penumbra apoptosis and behaviour following middle cerebral artery occlusion in rats. Clin Exp Pharmacol Physiol. 2010;37(2):185–192. doi:10.1111/j.1440-1681.2009.05257.x
   PubMed Web of Science ®Google Scholar
• He M, Kittur FS, Hung CY, et al. A novel plant-produced asialo-rhuEPO protects brain from ischemic damage without erythropoietic action. Transl Stroke Res. 2022;13(2):338–354. doi:10.1007/s12975-021-00943-z
   PubMed Web of Science ®Google Scholar
• Ishii T, Asai T, Oyama D, et al. Amelioration of cerebral ischemia-reperfusion injury based on liposomal drug delivery system with asialo-erythropoietin. J Control Release. 2012;160(1):81–87. doi:10.1016/j.jconrel.2012.02.004
   PubMed Web of Science ®Google Scholar
• Ishida T, Harada M, Wang XY, Ichihara M, Irimura K, Kiwada H. Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. J Control Release. 2005;105(3):305–317. doi:10.1016/j.jconrel.2005.04.003
   PubMed Web of Science ®Google Scholar
• Deng B, Li L, Gou X, et al. TAT-PEP enhanced neurobehavioral functional recovery by facilitating axonal regeneration and corticospinal tract projection after stroke. Mol Neurobiol. 2018;55(1):652–667. doi:10.1007/s12035-016-0301-9
   PubMed Web of Science ®Google Scholar
• Llorens F, Gil V, Del Río JA. Emerging functions of myelin-associated proteins during development, neuronal plasticity, and neurodegeneration. FASEB J. 2011;25(2):463–475. doi:10.1096/fj.10-162792
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang Y, Xia J, et al. Neuronal PirB upregulated in cerebral ischemia acts as an attractive theranostic target for ischemic stroke. J Am Heart Assoc. 2018;7(3):e007197. doi:10.1161/JAHA.117.007197
   PubMed Web of Science ®Google Scholar
• Long Y, Xiang Y, Liu S, et al. Macrophage membrane modified baicalin liposomes improve brain targeting for alleviating cerebral ischemia reperfusion injury. Nanomedicine. 2022;43:102547. doi:10.1016/j.nano.2022.102547
   PubMed Web of Science ®Google Scholar
• Zhao Y, Jiang Y, Lv W, et al. Dual targeted nanocarrier for brain ischemic stroke treatment. J Control Release. 2016;233:64–71. doi:10.1016/j.jconrel.2016.04.038
   PubMed Web of Science ®Google Scholar
• Li C, Li Z, Gong X, et al. Acidic tumor microenvironment-sensitive liposomes enhance colorectal cancer therapy by acting on both tumor cells and cancer-associated fibroblasts. Nanoscale. 2021;13(23):10509–10525. doi:10.1039/d1nr01506k
   PubMed Web of Science ®Google Scholar
• Abri Aghdam M, Bagheri R, Mosafer J, et al. Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release. J Control Release. 2019;315:1–22. doi:10.1016/j.jconrel.2019.09.018
   PubMed Web of Science ®Google Scholar
• Kim Y, Oh KT, Youn YS, Lee ES. pH-sensitive twin liposomes containing quercetin and laccase for tumor therapy. Biomacromolecules. 2022;23(9):3688–3697. doi:10.1021/acs.biomac.2c00571
   PubMedGoogle Scholar
• Rayamajhi S, Marchitto J, Nguyen T, Marasini R, Celia C, Aryal S. pH-responsive cationic liposome for endosomal escape mediated drug delivery. Colloids Surf B Biointerfaces. 2020;188:110804. doi:10.1016/j.colsurfb.2020.110804
   PubMed Web of Science ®Google Scholar
• Mei T, Kim A, Vong LB, et al. Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment - Synergistic effect of thrombolysis and antioxidant. Biomaterials. 2019;215:119209. doi:10.1016/j.biomaterials.2019.05.020
   PubMed Web of Science ®Google Scholar
• Katsura K, Ekholm A, Asplund B, Siesjö BK. Extracellular pH in the brain during ischemia: relationship to the severity of lactic acidosis. J Cereb Blood Flow Metab. 1991;11(4):597–599. doi:10.1038/jcbfm.1991.109
   PubMed Web of Science ®Google Scholar
• Menyhárt Á, Zölei-Szénási D, Puskás T, et al. Spreading depolarization remarkably exacerbates ischemia-induced tissue acidosis in the young and aged rat brain. Sci Rep. 2017;7(1):1154. doi:10.1038/s41598-017-01284-4
   PubMedGoogle Scholar
• Yao S, He C, Yuan P, et al. Real-time objective evaluation of the ischemic stroke through ph-responsive fluorescence imaging. Adv Healthc Mater. 2023;12(9):e2201981. doi:10.1002/adhm.202201981
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Fukuta T, Agato Y, et al. Suppression of cerebral ischemia/reperfusion injury by efficient release of encapsulated ifenprodil from liposomes under weakly acidic pH conditions. J Pharm Sci. 2019;108(12):3823–3830. doi:10.1016/j.xphs.2019.09.006
   PubMed Web of Science ®Google Scholar
• Filippov SK, Bogomolova A, Kaberov L, et al. Internal Nanoparticle Structure of Temperature-Responsive Self-Assembled PNIPAM-b-PEG-b-PNIPAM Triblock Copolymers in Aqueous Solutions: NMR, SANS, and Light Scattering Studies. Langmuir. 2016;32(21):5314–5323. doi:10.1021/acs.langmuir.6b00284
   PubMed Web of Science ®Google Scholar
• Saxena V, Gacchina Johnson C, Negussie AH, Sharma KV, Dreher MR, Wood BJ. Temperature-sensitive liposome-mediated delivery of thrombolytic agents. Int J Hyperthermia. 2015;31(1):67–73. doi:10.3109/02656736.2014.991428
   PubMed Web of Science ®Google Scholar
• Hsu HL, Chen JP. Preparation of thermosensitive magnetic liposome encapsulated recombinant tissue plasminogen activator for targeted thrombolysis. North-Holland. 2017. doi:10.1016/j.jmmm.2016.10.122
   Google Scholar
• Refaat A, Del Rosal B, Palasubramaniam J, et al. Near-infrared light-responsive liposomes for protein delivery: towards bleeding-free photothermally-assisted thrombolysis. J Control Release. 2021;337:212–223. doi:10.1016/j.jconrel.2021.07.024
   PubMed Web of Science ®Google Scholar
• Wan Y, Han J, Fan G, Zhang Z, Gong T, Sun X. Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity. Biomaterials. 2013;34(12):3020–3030. doi:10.1016/j.biomaterials.2012.12.051
   PubMed Web of Science ®Google Scholar
• Liu P, Chen G, Zhang J. A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives. Molecules. 2022;27(4):1372. doi:10.3390/molecules27041372
   PubMed Web of Science ®Google Scholar
• Liu Y, Castro Bravo KM, Liu J. Targeted liposomal drug delivery: a nanoscience and biophysical perspective. Nanoscale Horiz. 2021;6(2):78–94. doi:10.1039/d0nh00605j
   PubMed Web of Science ®Google Scholar
• Rabinovici R, Rudolph AS, Ligler FS, Yue TL, Feuerstein G. Liposome-encapsulated hemoglobin: an oxygen-carrying fluid. Circ Shock. 1990;32(1):1–17.
   PubMedGoogle Scholar
• Kawaguchi AT, Fukumoto D, Haida M, Ogata Y, Yamano M, Tsukada H. Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat: evaluation with photochemically induced thrombosis of the middle cerebral artery. Stroke. 2007;38(5):1626–1632. doi:10.1161/STROKEAHA.106.467290
   PubMed Web of Science ®Google Scholar
• Dvoriantchikova G, Barakat DJ, Hernandez E, Shestopalov VI, Ivanov D. Liposome-delivered ATP effectively protects the retina against ischemia-reperfusion injury. Mol Vis. 2010;16:2882–2890.
   PubMed Web of Science ®Google Scholar
• Campos-Martorell M, Cano-Sarabia M, Simats A, et al. Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats. Int J Nanomed. 2016;11:3035–3048. doi:10.2147/IJN.S107292
   PubMed Web of Science ®Google Scholar
• Sun R, Shang J, Yan X, et al. VCAM1 drives vascular inflammation leading to continuous cortical neuronal loss following chronic cerebral hypoperfusion. J Alzheimers Dis. 2023;91(4):1541–1555. doi:10.3233/JAD-221059
   PubMedGoogle Scholar
• Liu H, Jablonska A, Li Y, et al. Label-free CEST MRI detection of citicoline-liposome drug delivery in ischemic stroke. Theranostics. 2016;6(10):1588–1600. doi:10.7150/thno.15492
   PubMed Web of Science ®Google Scholar
• Zhao Y-Z, Lin M, Lin Q, et al. Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model. J Control Release. 2016;224:165–175. doi:10.1016/j.jconrel.2016.01.017
   PubMed Web of Science ®Google Scholar
• Park T, Amatya R, Min KA, Shin MC. Liposomal iron oxide nanoparticles loaded with doxorubicin for combined chemo-photothermal cancer therapy. Pharmaceutics. 2023;15(1):292. doi:10.3390/pharmaceutics15010292
   PubMed Web of Science ®Google Scholar
• Alkaff SA, Radhakrishnan K, Nedumaran AM, Liao P, Czarny B. Nanocarriers for stroke therapy: advances and obstacles in translating animal studies. Int J Nanomed. 2020;15:445–464. doi:10.2147/IJN.S231853
   PubMed Web of Science ®Google Scholar
• Fukuta T, Asai T, Yanagida Y, et al. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke. FASEB J. 2017;31(5):1879–1890. doi:10.1096/fj.201601209R
   PubMed Web of Science ®Google Scholar
• Peng T, Booher K, Moody MR, et al. Enhanced Cerebroprotection of Xenon-Loaded Liposomes in Combination with rtPA Thrombolysis for Embolic Ischemic Stroke. Biomolecules. 2023;13(8):1256. doi:10.3390/biom13081256
   PubMed Web of Science ®Google Scholar
• Huang H, Chen L, Chopp M, et al. The 2020 Yearbook of Neurorestoratology. Journal of Neurorestoratology. 2021;9(1):1–12. doi:10.26599/JNR.2021.9040002
   PubMed Web of Science ®Google Scholar
• Al-Ahmady ZS. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption. Expert Opin Drug Deliv. 2018;15(4):335–349. doi:10.1080/17425247.2018.1444601
   PubMed Web of Science ®Google Scholar
• Lakhan SE, Kirchgessner A, Tepper D, Leonard A. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol. 2013;4:32. doi:10.3389/fneur.2013.00032
   PubMed Web of Science ®Google Scholar
• Arai K, Lok J, Guo S, Hayakawa K, Xing C, Lo EH. Cellular mechanisms of neurovascular damage and repair after stroke. J Child Neurol. 2011;26(9):1193–1198. doi:10.1177/0883073811408610
   PubMed Web of Science ®Google Scholar
• Smith DA, Vaidya SS, Kopechek JA, et al. Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes. Ultrasound Med Biol. 2010;36(1):145–157. doi:10.1016/j.ultrasmedbio.2009.08.009
   PubMed Web of Science ®Google Scholar
• Shekhar H, Bader KB, Huang S, et al. In vitro thrombolytic efficacy of echogenic liposomes loaded with tissue plasminogen activator and octafluoropropane gas. Phys Med Biol. 2017;62(2):517–538. doi:10.1088/1361-6560/62/2/517
   PubMed Web of Science ®Google Scholar
• Asahi M, Rammohan R, Sumii T, et al. Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic stroke. J Cereb Blood Flow Metab. 2003;23(8):895–899. doi:10.1097/01.WCB.0000072570.46552.DF
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang M, Li S, et al. Selective ischemic-hemisphere targeting Ginkgolide B liposomes with improved solubility and therapeutic efficacy for cerebral ischemia-reperfusion injury. Asian J Pharm Sci. 2023;18(2):100783. doi:10.1016/j.ajps.2023.100783
   PubMed Web of Science ®Google Scholar
• Sun S, Lv W, Li S, et al. Smart liposomal nanocarrier enhanced the treatment of ischemic stroke through neutrophil extracellular traps and cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (cGAS-STING) pathway inhibition of ischemic penumbra. ACS Nano. 2023;17(18):17845–17857. doi:10.1021/acsnano.3c03390
   PubMed Web of Science ®Google Scholar
• Kakehata J, Yamaguchi T, Togashi H, et al. Therapeutic potentials of an artificial oxygen-carrier, liposome-encapsulated hemoglobin, for ischemia/reperfusion-induced cerebral dysfunction in rats. J Pharmacol Sci. 2010;114(2):189–197. doi:10.1254/jphs.10115fp
   PubMed Web of Science ®Google Scholar
• Chen YY, Gong ZC, Zhang MM, Huang ZH. Brain-targeting emodin mitigates ischemic stroke via inhibiting AQP4-mediated swelling and neuroinflammation. Transl Stroke Res. 2023. doi:10.1007/s12975-023-01170-4
   Web of Science ®Google Scholar
• Thomas RG, Kim JH, Kim JH, Yoon J, Choi KH, Jeong YY. Treatment of ischemic stroke by atorvastatin-loaded PEGylated liposome. Transl Stroke Res. 2024;15(2):388–398. doi:10.1007/s12975-023-01125-9
   PubMed Web of Science ®Google Scholar
• Wang K, Zhou W, Jin X, et al. Enhanced brain delivery of hypoxia-sensitive liposomes by hydroxyurea for rescue therapy of hyperacute ischemic stroke. Nanoscale. 2023;15(27):11625–11646. doi:10.1039/d3nr01071f
   PubMed Web of Science ®Google Scholar
• Ishii T, Asai T, Fukuta T, et al. A single injection of liposomal asialo-erythropoietin improves motor function deficit caused by cerebral ischemia/reperfusion. Int J Pharm. 2012;439(1–2):269–274. doi:10.1016/j.ijpharm.2012.09.026
   PubMedGoogle Scholar
• Wen Y, Zhang Z, Cai Z, Liu B, Wu Z, Liu Y. Ligustrazine-loaded borneol liposome alleviates cerebral ischemia-reperfusion injury in rats. ACS Biomater Sci Eng. 2022;8(11):4930–4941. doi:10.1021/acsbiomaterials.2c00847
   PubMedGoogle Scholar
• Wu S, Liao D, Li X, et al. Endogenous oleoylethanolamide crystals loaded lipid nanoparticles with enhanced hydrophobic drug loading capacity for efficient stroke therapy. Int J Nanomed. 2021;16:8103–8115. doi:10.2147/IJN.S344318
   PubMed Web of Science ®Google Scholar
• Fukuta T, Asai T, Sato A, et al. Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudil. Int J Pharm. 2016;506(1–2):129–137. doi:10.1016/j.ijpharm.2016.04.046
   PubMedGoogle Scholar
• Yu S, Li D, Shi A, et al. Multidrug-loaded liposomes prevent ischemic stroke through intranasal administration. Biomed Pharmacother. 2023;162:114542. doi:10.1016/j.biopha.2023.114542
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xin Z, Li N, et al. Nano-liposomes of lycopene reduces ischemic brain damage in rodents by regulating iron metabolism. Free Radic Biol Med. 2018;124:1–11. doi:10.1016/j.freeradbiomed.2018.05.082
   PubMed Web of Science ®Google Scholar
• Guo X, Jin X, Han K, et al. Iron promotes neurological function recovery in mice with ischemic stroke through endogenous repair mechanisms. Free Radic Biol Med. 2022;182:59–72. doi:10.1016/j.freeradbiomed.2022.02.017
   PubMed Web of Science ®Google Scholar
• Arul MR, Alahmadi I, Turro DG, et al. Fluorescent liposomal nanocarriers for targeted drug delivery in ischemic stroke therapy. Biomater Sci. 2023;11(24):7856–7866. doi:10.1039/d3bm00951c
   PubMed Web of Science ®Google Scholar
• Quan X, Han Y, Lu P, et al. Annexin V-modified platelet-biomimetic nanomedicine for targeted therapy of acute ischemic stroke. Adv Healthc Mater. 2022;11(16):e2200416. doi:10.1002/adhm.202200416
   PubMed Web of Science ®Google Scholar
• Hou J, Yang X, Li S, et al. Accessing neuroinflammation sites: monocyte/neutrophil-mediated drug delivery for cerebral ischemia. Sci Adv. 2019;5(7):eaau8301. doi:10.1126/sciadv.aau8301
   PubMed Web of Science ®Google Scholar
• Lu H, Li S, Dai D, et al. Enhanced treatment of cerebral ischemia-Reperfusion injury by intelligent nanocarriers through the regulation of neurovascular units. Acta Biomater. 2022;147:314–326. doi:10.1016/j.actbio.2022.05.021
   PubMed Web of Science ®Google Scholar
• Bai M, Cui N, Liao Y, et al. Astrocytes and microglia-targeted Danshensu liposomes enhance the therapeutic effects on cerebral ischemia-reperfusion injury. J Control Release. 2023;364:473–489. doi:10.1016/j.jconrel.2023.11.002
   PubMed Web of Science ®Google Scholar
• Bai Q, Han Y, Khan S, et al. A novel endoplasmic reticulum-targeted metal-organic framework-confined ruthenium (Ru) Nanozyme regulation of oxidative stress for central post-stroke pain. Adv Healthc Mater. 2024;13(2):e2302526. doi:10.1002/adhm.202302526
   PubMed Web of Science ®Google Scholar
• Quan X, Liang X, Ding Y, et al. Cryo-Shocked platelet coupled with ros-responsive nanomedicine for targeted treatment of thromboembolic disease. ACS Nano. 2023;17(7):6519–6533. doi:10.1021/acsnano.2c11865
   PubMed Web of Science ®Google Scholar
• Sun M, Miyazawa K, Pendekanti T, et al. Combination targeting of ‘platelets + fibrin’ enhances clot Anchorage efficiency of nanoparticles for vascular drug delivery. Nanoscale. 2020;12(41):21255–21270. doi:10.1039/d0nr03633a
   PubMed Web of Science ®Google Scholar
• Mishra D, Hubenak JR, Mathur AB. Nanoparticle systems as tools to improve drug delivery and therapeutic efficacy. J Biomed Mater Res A. 2013;101(12):3646–3660. doi:10.1002/jbm.a.34642
   PubMed Web of Science ®Google Scholar
• Wang Z, Pan J, Yuan R, Chen M, Guo X, Zhou S. Shell-sheddable polymeric micelles alleviate oxidative stress and inflammation for enhanced ischemic stroke therapy. Nano Lett. 2023;23(14):6544–6552. doi:10.1021/acs.nanolett.3c01567
   PubMed Web of Science ®Google Scholar
• Mutoh T, Mutoh T, Taki Y, Ishikawa T. Therapeutic potential of natural product-based oral nanomedicines for stroke prevention. J Med Food. 2016;19(6):521–527. doi:10.1089/jmf.2015.3644
   PubMed Web of Science ®Google Scholar
• Zhang A, Li J, Wang S, et al. Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy. Drug Deliv. 2021;28(1):2469–2479. doi:10.1080/10717544.2021.2000678
   PubMed Web of Science ®Google Scholar
• Liu T, Wang Y, Zhang M, et al. The optimization design of macrophage membrane camouflaging liposomes for alleviating ischemic stroke injury through intranasal delivery. Int J Mol Sci. 2024;25(5):2927. doi:10.3390/ijms25052927
   PubMed Web of Science ®Google Scholar